Does a cholesterol drug help prevent strokes?

Original Title

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

A drug called evolocumab was tested in people with hardening of the arteries who were already taking statins. It was compared to a fake treatment to see if it helped prevent strokes.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

Evolocumab reduced stroke risk even in patients already on statins with well-controlled cholesterol.

Many assumed that once LDL is lowered by statins, further reductions wouldn’t add much benefit—this study challenges that idea.

Practical Takeaways

For high-risk patients with atherosclerosis on statins, adding evolocumab may further reduce stroke risk.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.